Competition in the bariatric device space continues as several new weight loss approaches have surfaced in the past two months and yet another may soon enter the U.S. market. Apollo Endosurgery ...

Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the first commercial shipments of the OverStitch ...

Apollo Hospitals has introduced an incision-less bariatric surgery procedure, which requires no hospitalisation. A memorandum of understanding was signed on Wednesday by the hospital with Apollo ...

Similarly, the Apollo REVISE system is intended to perform bariatric procedures to facilitate weight loss among adult patients with obesity by enabling transoral outlet reduction as a revision to ...

Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT trial, published in The Lancet ...

The US Food and Drug Administration (FDA) has cleared for marketing the first devices indicated for endoscopic sleeve gastroplasty (ESG) and endoscopic bariatric revision, according to the ...

Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the assignment of Category I Current Procedural ...

Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is ...

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that ...